RNAC NASDAQ
Cartesian Therapeutics, Inc.
1W: -19.2%
1M: -3.0%
3M: -3.6%
YTD: -1.2%
1Y: -34.7%
3Y: -79.5%
5Y: -92.5%
$6.75
+0.07 (+1.05%)
Weekly Expected Move ±12.6%
$6
$6
$7
$8
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$2M
Revenue
-94.8% YoY
$-152M
Net Income
-296.2% YoY
$-77M
Free Cash Flow
-91.4% YoY
100.0%
Gross Margin
-33973.1%
Op. Margin
-50233.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE228.2%
ROA-41.5%
ROIC30.2%
Valuation
P/E-1.2
P/B-1.2
EV/EBITDA-0.8
Leverage
Debt/Equity-0.10
Current Ratio8.65
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z-3.94
Beneish M9.09